307 related articles for article (PubMed ID: 25337626)
1. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
[No Abstract] [Full Text] [Related]
2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
[No Abstract] [Full Text] [Related]
3. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
[No Abstract] [Full Text] [Related]
4. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2016 Oct; 91(42):485-99. PubMed ID: 27766828
[No Abstract] [Full Text] [Related]
5. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
[No Abstract] [Full Text] [Related]
6. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
[No Abstract] [Full Text] [Related]
7. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
[No Abstract] [Full Text] [Related]
8. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
[No Abstract] [Full Text] [Related]
9. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season.
Wkly Epidemiol Rec; 2016 Mar; 91(10):121-32. PubMed ID: 26971356
[No Abstract] [Full Text] [Related]
10. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season.
Wkly Epidemiol Rec; 2015 Mar; 90(11):97-108. PubMed ID: 25771542
[No Abstract] [Full Text] [Related]
11. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
[No Abstract] [Full Text] [Related]
12. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
[No Abstract] [Full Text] [Related]
13. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
[No Abstract] [Full Text] [Related]
14. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
[No Abstract] [Full Text] [Related]
15. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
[No Abstract] [Full Text] [Related]
16. Antigenic and genetic characteristics of influenza A(H5N1)and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2010 Oct; 85(42):418-24. PubMed ID: 20949701
[No Abstract] [Full Text] [Related]
17. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
[No Abstract] [Full Text] [Related]
18. Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2009 Oct; 84(41):432-6. PubMed ID: 19817020
[No Abstract] [Full Text] [Related]
19. Pandemic preparedness through vaccine development for avian influenza viruses.
Cargnin Faccin F; Perez DR
Hum Vaccin Immunother; 2024 Dec; 20(1):2347019. PubMed ID: 38807261
[TBL] [Abstract][Full Text] [Related]
20. Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines.
Nguyen-Van-Tam JS; Sellwood C
Expert Rev Vaccines; 2013 Aug; 12(8):825-8. PubMed ID: 23984955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
